ES8203363A1 - Antiallergic and antiulcer 1-oxo- 1H-thiazolo [3,2-a] pyrimidine-2- carboxamides and intermediates therefor - Google Patents

Antiallergic and antiulcer 1-oxo- 1H-thiazolo [3,2-a] pyrimidine-2- carboxamides and intermediates therefor

Info

Publication number
ES8203363A1
ES8203363A1 ES497066A ES497066A ES8203363A1 ES 8203363 A1 ES8203363 A1 ES 8203363A1 ES 497066 A ES497066 A ES 497066A ES 497066 A ES497066 A ES 497066A ES 8203363 A1 ES8203363 A1 ES 8203363A1
Authority
ES
Spain
Prior art keywords
formula
carbon atoms
antiulcer
thiazolo
antiallergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES497066A
Other languages
Spanish (es)
Other versions
ES497066A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8203363A1 publication Critical patent/ES8203363A1/en
Publication of ES497066A0 publication Critical patent/ES497066A0/en
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Abstract

Antiallergy and antiulcer agents having the formula (I), < IMAGE > and their pharmaceutically acceptable salts, wherein R1 and R2 taken separately are each hydrogen or C1-5 alkyl and R1 and R2 taken together are alkylene of 3 - 9 carbon atoms or phenylalkylene of 9 - 11 carbon atoms, with the proviso that the ring so formed is between 5- and 8-membered acids of the formula (II), < IMAGE > wherein R1 and R2 are as defined above and R3 is hydrogen, which are useful as intermediates for compounds of the formula (I), but in many instances also possess the same useful biological activity as do formula I compounds and intermediates of the formula II wherein R1 and R2 are defined as above, and R3 is alkyl of 1 to 4 carbon atoms, carbalkoxy of 2 to 5 carbon atoms, carbophenoxy or carbobenzoxy, are described.
ES497066A 1979-11-23 1980-11-21 A PROCEDURE FOR THE PREPARATION OF 1-OXO-1H-TIAZOLO- (3-2-A) PIRIMIDINE. Granted ES497066A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (2)

Publication Number Publication Date
ES8203363A1 true ES8203363A1 (en) 1982-04-01
ES497066A0 ES497066A0 (en) 1982-04-01

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497066A Granted ES497066A0 (en) 1979-11-23 1980-11-21 A PROCEDURE FOR THE PREPARATION OF 1-OXO-1H-TIAZOLO- (3-2-A) PIRIMIDINE.

Country Status (35)

Country Link
JP (1) JPS5687586A (en)
KR (1) KR830004322A (en)
AR (2) AR228859A1 (en)
AT (1) AT380883B (en)
AU (1) AU520995B2 (en)
BE (1) BE886319A (en)
CA (1) CA1143731A (en)
CH (1) CH649299A5 (en)
CS (1) CS241476B2 (en)
DD (1) DD154608A5 (en)
DE (2) DE3050491C2 (en)
DK (1) DK151811C (en)
EG (1) EG14929A (en)
ES (1) ES497066A0 (en)
FI (1) FI67706C (en)
FR (1) FR2470132A1 (en)
GB (1) GB2063862B (en)
GR (1) GR72132B (en)
GT (1) GT198066458A (en)
HU (1) HU179091B (en)
IE (1) IE50404B1 (en)
IL (1) IL61535A (en)
IN (1) IN154926B (en)
IT (1) IT1209373B (en)
LU (1) LU82950A1 (en)
NL (1) NL182565C (en)
NO (1) NO803521L (en)
NZ (1) NZ195596A (en)
PH (1) PH16666A (en)
PL (1) PL132354B1 (en)
PT (1) PT72090B (en)
SE (1) SE448732B (en)
SU (1) SU1042620A3 (en)
YU (1) YU41953B (en)
ZA (1) ZA807293B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (en) * 1987-03-30 1997-12-17 第一製薬株式会社 Heterocyclic amine derivative
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (en) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd Novel fused thiazolo and oxazolo pyrimidinones

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) * 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (en) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-OXO-1H-PYRIMIDO ANGLE CLAMP ON 6.1-B ANGLE CLAMP ON BENZTHIAZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
NZ195596A (en) 1984-05-31
PH16666A (en) 1983-12-13
FR2470132A1 (en) 1981-05-29
DE3043979C2 (en) 1986-08-21
NO803521L (en) 1981-05-25
IT8026176A0 (en) 1980-11-21
CS241476B2 (en) 1986-03-13
PL132354B1 (en) 1985-02-28
SU1042620A3 (en) 1983-09-15
YU41953B (en) 1988-02-29
CS782080A2 (en) 1985-06-13
CA1143731A (en) 1983-03-29
LU82950A1 (en) 1981-06-04
KR830004322A (en) 1983-07-09
YU295080A (en) 1983-06-30
AU6459580A (en) 1981-05-28
GB2063862A (en) 1981-06-10
ES497066A0 (en) 1982-04-01
JPS617432B2 (en) 1986-03-06
GB2063862B (en) 1983-06-22
DE3043979A1 (en) 1981-09-03
AU520995B2 (en) 1982-03-11
FI67706C (en) 1985-05-10
HU179091B (en) 1982-08-28
SE8008189L (en) 1981-05-24
DE3050491C2 (en) 1985-10-10
AR228859A1 (en) 1983-04-29
IE50404B1 (en) 1986-04-16
AR231296A1 (en) 1984-10-31
DD154608A5 (en) 1982-04-07
DK413180A (en) 1981-05-24
JPS5687586A (en) 1981-07-16
CH649299A5 (en) 1985-05-15
ZA807293B (en) 1981-12-30
NL182565C (en) 1988-04-05
BE886319A (en) 1981-05-25
EG14929A (en) 1989-01-30
PT72090B (en) 1981-09-29
SE448732B (en) 1987-03-16
IL61535A0 (en) 1980-12-31
DK151811B (en) 1988-01-04
GR72132B (en) 1983-09-19
IL61535A (en) 1984-06-29
NL8006362A (en) 1981-06-16
IE802418L (en) 1981-05-23
GT198066458A (en) 1982-05-15
FI67706B (en) 1985-01-31
IT1209373B (en) 1989-07-16
FR2470132B1 (en) 1983-07-29
ATA570780A (en) 1985-12-15
DK151811C (en) 1988-06-06
PL228008A1 (en) 1981-12-11
PT72090A (en) 1980-12-01
NL182565B (en) 1987-11-02
AT380883B (en) 1986-07-25
IN154926B (en) 1984-12-22
FI803628L (en) 1981-05-24

Similar Documents

Publication Publication Date Title
AU537028B2 (en) Imidazole derivatives
FI851261L (en) SUBSTITUTE BENSOPYRANER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL.
ES8501410A1 (en) Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same.
AU6729590A (en) Illudin analogs as anti-tumor agents
ES8203363A1 (en) Antiallergic and antiulcer 1-oxo- 1H-thiazolo [3,2-a] pyrimidine-2- carboxamides and intermediates therefor
NO164351C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ALKYL-L-PHENYL-2-PIPERAZINOALKYLPYRAZOLINE-3-ON COMPOUNDS.
AU535233B2 (en) Pyrimido-z-benzazepines
AU554959B2 (en) Triazolo(4,3-a) quinazolin-5-ones
ES8609344A1 (en) Cephalosporins and process for their preparation.
ES8500619A1 (en) Eburnane-oxime derivatives
ES8500620A1 (en) E-homo-eburnane derivatives
ES8504193A1 (en) Hexahydroindolonaphthyridine derivatives, their preparation and therapeutic use.